Foothills Medical Centre; Centre Dept of Medical Clinical Neuroscience

Calgary, Alberta T2N 2T9

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed